Cancer and atrial fibrillation: Epidemiology, mechanisms, and anticoagulation treatment

被引：28
作者：
Menichelli, Danilo [1 ]
Vicario, Tommasa [2 ,3 ]
Ameri, Pietro [4 ,6 ]
Toma, Matteo [4 ,6 ]
Violi, Francesco [1 ,5 ]
Pignatelli, Pasquale [1 ,5 ]
Pastori, Daniele [1 ]
机构：
[1] Sapienza Univ Rome, Dept Clin Internal Anesthesiol & Cardiovasc Sci, Rome, Italy
[2] Sapienza Univ Rome, Dept Gen Surg & Surg Specialties Paride Stefanini, Rome, Italy
[3] Policlin Tor Vergata Hosp, Emergency Dept, Rome, Italy
[4] IRCCS Osped Policlin San Martino, Cardiovasc Dis Unit, Genoa, Italy
[5] Mediterranea Cardioctr, Naples, Italy
[6] Univ Genoa, Dept Internal Med, Genoa, Italy
来源：
PROGRESS IN CARDIOVASCULAR DISEASES | 2021年 / 66卷
关键词：
Atrial fibrillation; Cancer; Oral anticoagulants; Chemotherapy; Radiotherapy; DOACs; DIRECT ORAL ANTICOAGULANTS; OXIDATIVE STRESS; RISK-FACTORS; CARDIOVASCULAR TOXICITY; POSITION PAPER; 2016; ESC; WARFARIN; SAFETY; THROMBOCYTOPENIA; THROMBOEMBOLISM;
D O I：
10.1016/j.pcad.2021.04.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Cancer patients are at an increased risk of developing atrial fibrillation (AF) and thrombosis. However, the management of anticoagulation in patients with both diseases may be challenging, and data on these patients are lacking. We summarize the current evidence on the incidence and prevalence of cancer in AF and vice versa and provide some practical considerations on the management of oral anticoagulation in specific clinical situations. Low-molecular weight heparins are not approved for thromboprophylaxis in AF, and management of warfarin can be difficult. The use of direct oral anticoagulants may be particularly attractive for their rapid onset/ offset action and lower bleeding risk. (c) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码：28 / 36
页数：9
相关论文
共 85 条
  • [1] Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study
    Adamsson Eryd, Samuel
    Smith, J. Gustav
    Melander, Olle
    Hedblad, Bo
    Engstrom, Gunnar
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2011, 26 (06) : 449 - 455
  • [2] Ahmed Niloy, 2016, J Atr Fibrillation, V9, P1458, DOI 10.4022/jafib.1458
  • [3] Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study
    Armenian, Saro H.
    Xu, Lanfang
    Ky, Bonnie
    Sun, Canlan
    Farol, Leonardo T.
    Pal, Sumanta Kumar
    Douglas, Pamela S.
    Bhatia, Smita
    Chao, Chun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (10) : 1122 - +
  • [4] The incidence of atrial fibrillation among patients with AL amyloidosis undergoing high-dose melphalan and stem cell transplantation: experience at a single institution
    Arun, M.
    Brauneis, D.
    Doros, G.
    Shelton, A. C.
    Sloan, J. M.
    Quillen, K.
    Ruberg, F. L.
    Sanchorawala, V.
    Varga, C.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 (09) : 1349 - 1351
  • [5] Inflammation as a risk factor for atrial fibrillation
    Aviles, RJ
    Martin, DO
    Apperson-Hansen, C
    Houghtaling, PL
    Rautaharju, P
    Kronmal, RA
    Tracy, RP
    Van Wagoner, DR
    Psaty, BM
    Lauer, MS
    Chung, MK
    [J]. CIRCULATION, 2003, 108 (24) : 3006 - 3010
  • [6] Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery
    Bhave, Prashant D.
    Goldman, L. Elizabeth
    Vittinghoff, Eric
    Maselli, Judith
    Auerbach, Andrew
    [J]. AMERICAN HEART JOURNAL, 2012, 164 (06) : 918 - 924
  • [7] Mechanisms and clinical course of cardiovascular toxicity of cancer treatment II. Hematology
    Breccia, Massimo
    Carver, Joseph R.
    Szmit, Sebastian
    Jurczak, Wojciech
    Salvatorelli, Emanuela
    Minotti, Giorgio
    [J]. SEMINARS IN ONCOLOGY, 2019, 46 (06) : 403 - 407
  • [8] Efficacy and Safety of Nonvitamin K Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer: A Study-Level Meta-Analysis
    Cavallari, Ilaria
    Verolino, Giuseppe
    Romano, Silvio
    Patti, Giuseppe
    [J]. THROMBOSIS AND HAEMOSTASIS, 2020, 120 (02) : 314 - 321
  • [9] The association between the use of non-steroidal anti-inflammatory drugs and atrial fibrillation: A nationwide case-control study
    Chao, Tze-Fan
    Liu, Chia-Jen
    Chen, Su-Jung
    Wang, Kang-Ling
    Lin, Yenn-Jiang
    Chang, Shih-Lin
    Lo, Li-Wei
    Hu, Yu-Feng
    Tuan, Ta-Chuan
    Wu, Tsu-Juey
    Chen, Tzeng-Ji
    Tsao, Hsuan-Ming
    Chen, Shih-Ann
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (01) : 312 - 316
  • [10] Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKETAF
    Chen, Sean T.
    Hellkamp, Anne S.
    Becker, Richard C.
    Berkowitz, Scott D.
    Breithardt, Guenter
    Fox, Keith A. A.
    Hacke, Werner
    Halperin, Jonathan L.
    Hankey, Graeme J.
    Mahaffey, KennethW.
    Nessel, Christopher C.
    Piccini, Jonathan P.
    Singer, Daniel E.
    Patel, Manesh R.
    Melloni, Chiara
    [J]. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2019, 5 (02) : 145 - 152
123456789